Early detection of prostate cancer
Wednesday 19 November 2025One year of the prostate consultation: promising results in early detection of prostate cancer
The initial results after one year of the Prostate Consultation, a collaboration between the NKI Center for Early Diagnostics and SALT, are promising. These results show that the Prostate Consultation is a valuable addition to primary care and that early detection can be implemented safely and efficiently.
Wednesday 19 November 2025Prostate cancer awareness month: know your risk
Did you know that men of Surinamese, Caribbean, and African ancestry have a higher risk of developing prostate cancer? And that the disease often develops more aggressively in these men? This makes early detection vital, even before symptoms occur.
Wednesday 12 November 2025Improving prostate cancer risk assessment using abdominal ultrasound
Over the past year, researchers at the NKI Center for Early Diagnostics have been investigating a new, more patient-friendly method to assess the risk of prostate cancer in men with elevated PSA levels. The first promising results of this study were recently published in the scientific journal The Prostate.
Monday 18 August 2025NKI expands its collaboration with Andros Clinics
The Netherlands Cancer Institute and Andros Clinics are intensifying their collaboration to help men with an increased risk of prostate cancer more quickly and effectively. Together, we ensure that every man is directed to the place that best matches his situation as quickly as possible. This not only improves the quality of care but also ensures that patients receive help faster.
Thursday 1 August 2024The NKI starts offering prostate consultations at SALT in Zaandam
The NKI Center for Early Diagnostics has initiated a collaboration with diagnostic center SALT to improve early detection of prostate cancer. Last week the NKI started offering prostate consultations at SALT in Zaandam. The goal of the collaboration is scientific research into a new, risk-weighted care pathway to better detect aggressive tumors and decrease diagnoses and treatment for low-grade prostate cancer. The study is financed by KWF Dutch Cancer Society.